Advertisement

Topics

Inno Biologics Sdn. Bhd Company Profile

10:00 EDT 27th May 2017 | BioPortfolio

Inno Biologics Sdn. Bhd., a contract manufacturer, operates a cGMP manufacturing facility for the production of biopharmaceutical API. It is the flagship biotech company of Inno Bio Ventures Sdn. Bhd., a Malaysian Ministry of Finance Incorporated Company with a close affiliation with Ministry of Science, Technology and Innovation of Malaysia.Our services cover all stages of the production of mammalian cell-based therapeutic proteins and monoclonal antibodies, from DNA recombination work and bioprocess development to cGMP manufacturing. Our reliable, rapid and cost-effective services will reduce your risks, costs and time investment so you can get your products on the market in a timely manner.

Location

Lot 1, Persiaran Negeri BBN, Putra Nilai
Nilai
Negeri Sembilan
71800
Malaysia

Contact

Phone: 6 06 799 6661
Fax: 6 06 799 6660
Email: info@innobiologics.com


News Articles [680 Associated News Articles listed on BioPortfolio]

INNO-KOM

AGC firma un acuerdo de adquisición de la destacada CDMO biofarmacéutica, CMC Biologics

David Kauffmann, presidente de CMC Biologics, comentó: "Estoy emocionado porque CMC Biologics se convierta en parte de AGC, una compañía de nivel mundial comprometida Read more...

AGC signe un accord visant à acquérir la CDMO biopharmaceutique leader CMC Biologics

David Kauffmann, président de CMC Biologics, a déclaré : « Je suis ravi que CMC Biologics devienne partie intégrante d'AGC, qui est une société de classe Read more...

AGC expanding CDMO biz through $500m CMC Biologics buy

AGC Asahi Glass has signed an agreement to buy CMC Biologics, the second biologics CDMO acquisition for the Japanese chemicals firm in three months.

AGC assina acordo para a aquisição da CMC Biologics, uma importante empresa biofarmacêutica ...

David Kauffmann, presidente da CMC Biologics, disse. "Estou animado por a CMC Biologics vir a ser parte da AGC, uma empresa de nível internacional Read more...

Qu Biologics’ project with University of Ottawa scientist awarded an innovation grant

VANCOUVER, BC & OTTAWA, ON – Qu Biologics Inc., a company that has developed a unique platform of immunotherapies designed to “reboot” the body’s innate immune system, is partnering with a...

Cobra Biologics embarks on £15 million gene therapy manufacturing expansion

Cobra Biologics, an international contract development and manufacturing organization (CDMO) of biologics…

AGC Asahi Glass Agrees to Acquire CMC Biologics

AGC Asahi Glass agreed to acquire CMC Biologics, a contract manufacturing and development organization (CDMO), in a deal that is expected to close next month. AGC manufactures glass, chemicals, and hi...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [106 Associated PubMed Articles listed on BioPortfolio]

Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.

Rapid drug desensitization (RDD) induces a temporary tolerance to biologics which induce hypersensitivity reactions (HSRs). Data are limited regarding the use of RDD outside the USA. Our purpose was t...

Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

Biologic disease-modifying anti-rheumatic drugs (DMARDs: referred to as biologics) are effective in treating rheumatoid arthritis (RA), however there are few head-to-head comparison studies. Our syste...

Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.

There are roughly 5 to 10 million persons infected with human T-lymphotropic virus type 1 (HTLV-1) worldwide, and the safety of treating this population with biologics remains poorly understood.

Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.

The effectiveness of biologics for psoriasis shows heterogeneity among patients. With pharmacogenetic markers, it might be possible to predict treatment response.

Nanofluidic device for continuous multiparameter quality assurance of biologics.

Process analytical technology (PAT) is critical for the manufacture of high-quality biologics as it enables continuous, real-time and on-line/at-line monitoring during biomanufacturing processes. The ...

Clinical Trials [60 Associated Clinical Trials listed on BioPortfolio]

INNO-105 in Patients With Solid Tumors

The safety, tolerability and pharmacokinetics of INNO-105, an investigational anticancer drug, are being studied in patients with solid tumors.

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [223 Associated Companies listed on BioPortfolio]

Inno Biologics Sdn. Bhd

Inno Biologics Sdn. Bhd., a contract manufacturer, operates a cGMP manufacturing facility for the production of biopharmaceutical API. It is the flagship biotech company of Inno Bio Ventures Sdn. Bhd....

inno GmbH

inno group is a strategic management consulting company located in Germany, France, Austria, Sweden and with a representation in Russia.inno group designs and implements innovation strategies for Regi...

Innocorp, ltd.

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

More Information about "Inno Biologics Sdn. Bhd" on BioPortfolio

We have published hundreds of Inno Biologics Sdn. Bhd news stories on BioPortfolio along with dozens of Inno Biologics Sdn. Bhd Clinical Trials and PubMed Articles about Inno Biologics Sdn. Bhd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inno Biologics Sdn. Bhd Companies in our database. You can also find out about relevant Inno Biologics Sdn. Bhd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record